Nasal Antiseptics Market - Top Companies and Manufacturers

  • Report ID: 5650
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Nasal Antiseptics Landscape

    • BlueWillow Biologics®
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Silicon Valley Innovations, Inc. (SVI)
    • Siemens Healthineers
    • Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Horiba Ltd.
    • Danaher Corp.
    • OmegaQuant LLC
    • Sysmex Corporation
    • EKF Diagnostics Holdings Plc

Browse Key Market Insights with Data Illustration:

In the News

  • BlueWillow Biologics®, a clinical-stage biopharmaceutical business, announced the launch of NanoBio® Protect (NanoBio®), the first over-the-counter (OTC) nasal antiseptic that is hydrating, alcohol-free, and has been shown to destroy 99.99% of pathogens on contact.
  • Silicon Valley Innovations, Inc. (SVI) introduced NasoClenz®, an inventive device created by famous surgeon, inventor, and med-tech entrepreneur Dr. Gail Lebovic. Due to Dr. Lebovic's recognition of the need to maintain good nasal hygiene for both surgical results and general health, the NasoClenz product line was developed.

Author Credits:  Radhika Pawar


  • Report ID: 5650
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of nasal antiseptics is evaluated at USD 368.93 million.

The nasal antiseptics market size was over USD 353.92 million in 2024 and is poised to exceed USD 692.59 million by 2037, witnessing over 5.3% CAGR during the forecast period i.e., between 2025-2037. Increased research & development activities in the antibiotics industry, increasing elderly population worldwide, and growing awareness regarding the benefits of the product will boost the market growth.

North America industry is estimated to hold largest revenue share of 36% by 2037, due to rising sinus infection prevalence in the region.

The major players in the market are BlueWillow Biologics®, Silicon Valley Innovations, Inc. (SVI), Siemens Healthineers, Hoffmann-La Roche Ltd., Abbott Laboratories, Horiba Ltd., Danaher Corp., OmegaQuant LLC, Sysmex Corporation, EKF Diagnostics Holdings Plc, Maruishi Pharmaceutical. Co., Ltd., 3M, NIHON CHOUZAI Co., Ltd., Shionogi & Co., Ltd., Aculys Pharma, Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample